We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ortho Clinical Diagnostics Presents Cardiac Advances at EuroMedLab 2019

By LabMedica International staff writers
Posted on 20 May 2019
Print article
Image: The Multi-Test VITROS chemistry product slides (Photo courtesy of Ortho Clinical Diagnostics).
Image: The Multi-Test VITROS chemistry product slides (Photo courtesy of Ortho Clinical Diagnostics).
Ortho Clinical Diagnostics (Raritan, NJ, USA) sponsored an educational workshop on high-sensitivity troponin assays and presented five scientific posters at EuroMedLab 2019, the 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which took place from May 19-23, 2019, at the CCIB - Centre Convencions Internacional in Barcelona. Ortho also displayed its new multi-test VITROS Chemistry Product Slides, the VITROS Cell, a compact automation solution allowing two VITROS XT 7600 instruments (launched in 2018) to operate as a seamless solution, and the VITROS XT 7600 Integrated System at its booth during the congress.

Ortho, an in vitro diagnostics company serving the clinical laboratory and immunohematology communities, offers sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions across hospitals, hospital networks, blood banks and labs in more than 125 countries and territories.

In addition to the educational workshop, "The Clinical Use and Performance of High-Sensitivity Troponin Assays with the Esc 0-1 Algorithm: Overcoming Challenges in Implementation," Ortho presented the following five scientific posters at EuroMedLab:

- Evaluation of the New Multi-Test VITROS Chemistry Product Slides on the VITROS XT 7600 Integrated System
- Sigma Metrics for Assessing the Analytical Quality of the New Multi-Test VITROS XT Chemistry Products Slides
- Precision of the New Multi-Test VITROS Chemistry Product Slides on the VITROS XT 7600 Integrated System
- Performance Evaluation of the VITROS hs Troponin I Assay on the VITROS ECi/ECiQ and 3600 Immunodiagnostic and VITROS 5600/XT 7600 Integrated Systems
- Performance Evaluation of the VITROS Immunodiagnostic Products B·R·A·H·M·S PCT Assay on the VITROS 3600 Immunodiagnostic System

"Ortho is committed to staying ahead of the rapidly evolving clinical lab environment," said Joan Martin, executive vice president and head of Ortho's EMEA region." At this year's EuroMedLab, we're proud to be presenting data on two of our just-launched, key product offerings: our new high-sensitivity troponin assay and Ortho's VITROS XT MicroSlide. The XT MicroSlide can perform two tests simultaneously to improve lab workflow performance, productivity and clinical outcomes."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more